cognitive cybersecurity intelligence

News and Analysis


driving an era in autoimmune and cancer care

Immunometabolism therapies could offer a way to reverse inflammation and cure diseases, according to Neil Weir, CEO of Sitryx. This emerging field in therapeutics looks at the overlap between metabolic pathways and the immune cell synthesis process, allowing very specific targeted therapies which influence the immune system without causing dangerous side effects. Sitryx has three drugs in various stages of development for a variety of autoimmune diseases, while Texas-based ImmunoMet is likewise developing lixumistat, which has various uses including in pancreatic cancer trials.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

A Better Connected Care Journey

The article urges healthcare organizations to move towards integrated, digitally enabled care delivery, replacing outdated point solutions. It acknowledges some may need help overcoming hurdles.